"Our latest investment reflects our commitment to address the unmet needs in non-communicable diseases, enable high-value job creation and boost medical innovation in the country," AstraZeneca Executive VP for International Region Leon Wang said.
The company believes, this investment commitment across AstraZeneca's business footprint in India will make a positive impact. It also aligns closely with the government's vision for healthcare and innovation, Wang said.
This investment commitment will be aimed at strengthening manufacturing, clinical operations, patient safety and regulatory science, IT services and commercial operations, AstraZeneca said.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)